Alternatively, higher concentrations of inflammatory and endothelial dysfunction markers among lymphoma patients including interleukin 6 are significantly correlated with decreased AMH concentrations [35] as well as CVD risk [36], suggesting that AMH may also be linked with CVD through this pathway. This evidence concerns the gene IL6 and endothelial dysfunction.